PMID- 35069527 OWN - NLM STAT- MEDLINE DCOM- 20220228 LR - 20220228 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 12 DP - 2021 TI - PP2Cdelta Controls the Differentiation and Function of Dendritic Cells Through Regulating the NSD2/mTORC2/ACLY Pathway. PG - 751409 LID - 10.3389/fimmu.2021.751409 [doi] LID - 751409 AB - Dendritic cells (DCs) are recognized as a key orchestrator of immune response and homeostasis, deregulation of which may lead to autoimmunity such as experimental autoimmune encephalomyelitis (EAE). Herein we show that the phosphatase PP2Cdelta played a pivotal role in regulating DC activation and function, as PP2Cdelta ablation caused aberrant maturation, activation, and Th1/Th17-priming of DCs, and hence induced onset of exacerbated EAE. Mechanistically, PP2Cdelta restrained the expression of the essential subunit of mTORC2, Rictor, primarily through de-phosphorylating and proteasomal degradation of the methyltransferase NSD2 via CRL4(DCAF2) E3 ligase. Loss of PP2Cdelta in DCs accordingly sustained activation of the Rictor/mTORC2 pathway and boosted glycolytic and mitochondrial metabolism. Consequently, ATP-citrate lyse (ACLY) was increasingly activated and catalyzed acetyl-CoA for expression of the genes compatible with hyperactivated DCs under PP2Cdelta deletion. Collectively, our findings demonstrate that PP2Cdelta has an essential role in controlling DCs activation and function, which is critical for prevention of autoimmunity. CI - Copyright (c) 2022 Lv, Jin, Liang, Wu, Kang, Su, Dong, Wang, Ma and Shi. FAU - Lv, Nianyin AU - Lv N AD - Department of Immunology, Nanjing University of Chinese Medicine, Nanjing, China. FAU - Jin, Sufeng AU - Jin S AD - Department of Clinical Laboratory, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China. AD - Key Lab of Inflammation and Immunoregulation, Hangzhou Normal University School of Medicine, Hangzhou, China. FAU - Liang, Zihao AU - Liang Z AD - Department of Immunology, Nanjing University of Chinese Medicine, Nanjing, China. FAU - Wu, Xiaohui AU - Wu X AD - Department of Immunology, Nanjing University of Chinese Medicine, Nanjing, China. FAU - Kang, Yanhua AU - Kang Y AD - Department of Immunology, Nanjing University of Chinese Medicine, Nanjing, China. AD - Key Lab of Inflammation and Immunoregulation, Hangzhou Normal University School of Medicine, Hangzhou, China. FAU - Su, Lan AU - Su L AD - Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, China. FAU - Dong, Yeping AU - Dong Y AD - Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, China. FAU - Wang, Bingwei AU - Wang B AD - College of Medicine and Integrated Medicine, Nanjing University of Chinese Medicine, Nanjing, China. FAU - Ma, Tonghui AU - Ma T AD - College of Medicine and Integrated Medicine, Nanjing University of Chinese Medicine, Nanjing, China. FAU - Shi, Liyun AU - Shi L AD - Department of Immunology, Nanjing University of Chinese Medicine, Nanjing, China. AD - Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220107 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - EC 2.1.1.43 (Histone-Lysine N-Methyltransferase) RN - EC 2.1.1.43 (WHSC1 protein, mouse) RN - EC 2.3.3.8 (ATP Citrate (pro-S)-Lyase) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 2) RN - EC 3.1.3.16 (Ppm1d protein, mouse) RN - EC 3.1.3.16 (Protein Phosphatase 2C) SB - IM MH - ATP Citrate (pro-S)-Lyase/genetics/*immunology MH - Animals MH - Cell Differentiation/genetics/*immunology MH - Dendritic Cells/*immunology MH - Female MH - Histone-Lysine N-Methyltransferase/genetics/*immunology MH - Mechanistic Target of Rapamycin Complex 2/genetics/*immunology MH - Mice MH - Mice, Knockout MH - Protein Phosphatase 2C/genetics/*immunology MH - Signal Transduction/genetics/*immunology PMC - PMC8777276 OTO - NOTNLM OT - PP2Cdelta OT - autoimmunity OT - dendritic cells OT - differentiation OT - mTORC2 COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/01/25 06:00 MHDA- 2022/03/01 06:00 PMCR- 2021/01/01 CRDT- 2022/01/24 08:49 PHST- 2021/08/01 00:00 [received] PHST- 2021/12/16 00:00 [accepted] PHST- 2022/01/24 08:49 [entrez] PHST- 2022/01/25 06:00 [pubmed] PHST- 2022/03/01 06:00 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2021.751409 [doi] PST - epublish SO - Front Immunol. 2022 Jan 7;12:751409. doi: 10.3389/fimmu.2021.751409. eCollection 2021.